False positive troponin-a true problem

Journal of Medical Biochemistry

Volumn 32, Issue 3, 2013, Pages 197-206

  Koraćević, Goran ^a   Ćosić, Vladan ^a   Stojanović, Ivana ^b  

^a Clinical Centre   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Acute coronary syndrome; False positive; Myocardial infarction; Troponin

Indexed keywords

TROPONIN;

ACUTE HEART INFARCTION; ANGIOGRAPHY; ARTICLE; FALSE POSITIVE RESULT; HEART INJURY; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; PATHOGENESIS;

EID: 84881503989     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/jomb-2013-0021     Document Type: Article

References (85)

1. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010; 31: 2197-204.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF /AHA/WHF Task Force for the Redefinition of Myo-cardial Infarction. Universal definition of myocardial in-farction. Eur Heart J 2007; 28: 2525-38.
3. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11. Review.
4. Iijima R, Ndrepepa G, Mehilli J, et al. Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment. Clin Res Cardiol 2008; 97: 160-8.
5. Bionda C, Rousson R, Collin-Chavagnac D, Manchon M, Chikh K, Charrié A. Unnecessary coronary angiography due to false positive troponin I results in a 51-year-old man. Clin Chim Acta 2007; 378: 225-6.
6. Gupta S, de Lemos J. Use and Misuse of Cardiac Tro-ponins in Clinical Practice. Prog Cardiovasc Dis 2007; 50: 151-65.
7. McNeil A. The trouble with Troponin. Heart Lung Circ 2007; 16 Suppl 3: S13-6.
8. Fye B. Troponin Trumps Common Sense. J Am Coll Cardiol 2006; 48: 2357-8.
9. Grines CL, Dixon S. A nail in the coffin of troponin mea-surements after percutaneous coronary intervention. J Am Coll Cardiol 2011; 57: 662-3.
10. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-67.
11. Demarchi MS, Regusci L, Fasolini F. Electrocardiographic changes and false-positive troponin I in a patient with acute cholecystitis. Case Rep Gastroenterol 2012; 6: 410-14.
12. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011; 58: 1819-24.
13. Petrie CJ, Weir RA, Reid A, Rodgers J, Brady AJ. A cautionary tale-false-positive troponin I in pregnancy. QJM 2011; 104: 439-40.
14. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008; 155: 208-14.
15. Makaryus AN, Makaryus MN, Hassid B. Falsely elevated cardiac troponin I levels. Clin Cardiol 2007; 30: 92-4.
16. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004; 125: 1877-84.
17. Lum G, Solarz D, Farney L. False Positive Cardiac Troponin Results in Patients Without Acute Myocardial Infarction. Lab Med 2006; 37: 546-50.
18. Kazmierczak SC, Sekhon H, Richards C. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference. Int J Cardiol 2005; 101: 27-31.
19. Krahn J, Parry DM, Leroux M, Dalton J. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clin Biochem 1999; 32: 477-80.
20. Wu AH. Cardiac troponin: friend of the cardiac physician, foe to the cardiac patient? Circulation 2006; 114: 1673-5.
21. Ghali S, Lewis K, Kazan V, Altorok N, Taji J, Taleb M, Lanka K, Assaly R. Fluctuation of Spuriously Elevated Troponin I: A Case Report. Case Reports in Critical Care 2012; 2012: 1-4.
22. Mühling O, El-Nounou M, Schäfer C, Mühlbayer D, Tympner C, Behr J. A 52-year-old patient with positive troponin, iron deficiency anemia and known sarcoidosis. Internist (Berl) 2006; 47: 1279-82.
23. Fleming SM, O'Byrne L, Finn J, Grimes H, Daly KM. False-positive cardiac troponin I in a routine clinical population. Am J Cardiol 2002; 89: 1212-15.
24. Schwarzmeier JD, Hamwi A, Preisel M, et al. Positive troponin T without cardiac involvement in inclusion body myositis. Hum Pathol 2005; 36: 917-21.
25. James SK, Lindahl B, Armstrong P, et al GUSTO-IV ACS Investigators. A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. Int J Cardiol 2004; 93: 113-20.
26. Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006; 369: 179-87.
27. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-67.
28. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I mea-sured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55: 52-8.
29. Wu AH, Akhigbe P, Wians F. Long-term biological variation in cardiac troponin I. Clin Biochem 2012; 45: 714-16.
30. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012; 33(5): 579-86.
31. Zhu Y, Jenkins MM, Brass DA, Ravago PG, Horne BD, Dean SB, Drayton N. Heterophilic antibody interference in an ultra-sensitive 3-site sandwich troponin I immuno-assay. Clin Chim Acta 2008; 395: 181-2.
32. Apple FS, Jesse RL, Newby LK, et al.; IFCC Committee on Standardization of Markers of Cardiac Damage
33. Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Panteghini M, Tate J; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007; 53: 547-51.
34. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010; 56: 941-3.
35. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012; 60: 2427-63.
36. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000; 102: 1216-20.
37. Wu AHB, Apple FS, Gibler WB, Jesse RJ, Warshaw MM, Valdes R. National academy of clinical biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999; 45: 1104-21.
38. Beyne P, Vigier JP, Bourgoin P, Vidaud M. Comparison of single and repeat centrifugation of blood specimens collected in BD evacuated blood collection tubes containing a clot activator for cardiac troponin I assay on the ACCESS analyzer. Clin Chem 2000; 46: 1869-70.
39. Strathmann FG, Ka MM, Rainey PM, Baird GS. Use of the BD vacutainer rapid serum tube reduces false-po s-itive results for selected Beckman Coulter Unicel DxI immunoassays. Am J Clin Pathol 2011; 136: 325-9.
40. McClennen S, Halamka JD, Horowitz GL, Kannam JP, Ho KK. Clinical prevalence and ramifications of false-positive cardiac troponin I elevations from the Abbott AxSYM analyzer. Am J Cardiol 2003; 91: 1125-7.
41. Koch CD, Wockenfus AM, Saenger AK, Jaffe AS, Karon BS. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. Clin Biochem 2012; 45: 842.
42. Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 2007; 167: 276-81.
43. Morrow DA, Cannon CP, Jesse RL, et al.; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007; 53: 552-74.
44. Bassand JP, Hamm CW, Ardissino D, et al. W; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, et al.; Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-STsegment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Seg-ment Elevation Acute Coronary Syndromes of the Euro-pean Society of Cardiology. Eur Heart J 2007; 28: 1598-660.Araihttp: eurheartj.oxfordjournals.org.nainfo.nbs.Bg.ac.yu:2048cgicontentfull28101175- COR1#COR1
45. A. False positive or true positive troponin in patients presenting with chest pain but 'normal' coronary arteries: lessons from cardiac MRI. Eur Heart J 2007; 28: 1175-7.
46. Jaffe A. Elevations in cardiac troponin measurements: False false-positives. The real truth. Cardiovasc Toxicol 2001; 1: 87-92.
47. Pretorius CJ, Wilgen U, Ungerer JP. Serial cardiac troponin differences measured on four contemporary analyzers: relative differences, actual differences and reference change values compared. Clin Chim Acta 2012 Nov 12; 413(21-22): 1786-91.
48. Gassenmaier T, Buchner S, Birner C, Jungbauer CG, Resch M, Debl K, Endemann DH, Riegger GA, Lehn P, Schmitz G, Luchner A. High-sensitive Troponin I in acute cardiac conditions: implications of baseline and sequential measurements for diagnosis of myocardial infarction. Atherosclerosis 2012; 222: 116-22.
49. Wong P, Murray S, Ramsewak A, Robinson A, van Heyningen C, Rodrigues E. Raised cardiac troponin T levels in patients without acute coronary syndrome. Postgrad Med J 2007; 83: 200-5.
50. Wu AH. Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series. Clin Chim Acta 2009; 401: 170-4.
51. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306: 2684-93.
52. Myint PK, Al-Jawad M, Chacko SM, Chu GS, Vowler SL, May HM. Prevalence, Characteristics and Outcomes of People Aged 65 Years and Over with an Incidental Rise in Cardiac Troponin I. An Observational Prospective Cohort Study. Cardiol 2007; 110: 62-7.
53. Saiki A, Iwase M, Takeichi Y, et al. Diversity of the elevation of serum cardiac troponin I levels in patients during their first visit to the emergency room. Circ J 2007; 71: 1458-62.
54. Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skep-pholm M, Malmqvist K, et al. Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis. Angiology 2012; 63: 500-3.
55. McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: a report from the Activate-SF registry. Arch Intern Med 2012; 172: 864-71.
56. Nfor T, Kostopoulos L, Hashim H, Jan MF, Gupta A, Bajwa T, et al. Identifying false-positive ST-Elevation myocardial infarction in emergency department patients. J Emerg Med 2012; 43: 561-7.
57. Kim SH, Oh SH, Choi SP, Park KN, Kim YM, Youn CS. The appropriateness of single page of activation of the cardiac catheterization laboratory by emergency physician for patients with suspected ST-segment elevation myocardial infarction: a cohort study. Scand J Trauma Resusc Emerg Med 2011; 19: 50.
58. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Committee for Practice Guidelines
59. Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
60. Schulz O, Paul-Walter C, Lehmann M, et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. Am J Cardiol 2007; 100: 764-9.
61. Zethelius, N. Johnston and P. Venge. Troponin I as a predictor of coronary heart disease and mortality in 70-yearold men: a community-based cohort study. Circulation 2006; 113: 1071-8.
62. Irfan A, Twerenbold R, Reiter M, Reichlin T, Stelzig C, Freese M, et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med 2012; 125: 491-8.
63. Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A, Maisel AS. Biomarkers in acute myocardial injury. Transl Res 2012; 159: 252-64.
64. Vasikaran SD, Bima A, Botros M, Sikaris KA. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays-an update from the Canadian society of clinical chemists (CSCC); the case for age related acute myocardial infarction (AMI) cut-offs. Clin Biochem 2012; 45: 513-14.
65. Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, Meissner J, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011; 32: 1379-89.
66. Olivieri F, Galeazzi R, Giavarina D, Testa R, Abbatecola AM, Çeka A, et al. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech Ageing Dev 2012; 133: 30-5.
67. Iversen K, Køber L, Gøtze JP, Dalsgaard M, Nielsen H, Boesgaard S, et al. Troponin T is a strong marker of mortality in hospitalized patients. Int J Cardiol 2012; 29: pii: S0167-5273(12)01380-0. doi: 10.1016/j. ijcard.2012. 10.006.
68. Collinson PO, Gaze DC. Biomarkers of cardiovascular damage and dysfunction-an overview. Heart Lung Circ 2007; 16 Suppl 3: 71-82. Review.
69. Schulz O, Kirpal K, Stein J, et al. Importance of low concentrations of cardiac troponins. Clin Chem 2006; 52: 1614-15.
70. DeFilippi CR, De Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010; 304: 2494-15.
71. Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM; ARIC Study Investigators. Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol 2013; 23: 66-73.
72. Dokainish H, Pillai M, Murphy SA, et al.; TACTICS-TIMI-18 Investigators. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005; 45: 19-24.
73. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial in-farc tion: a report of the American College of Cardio-logy/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Gu i de-lines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emer gency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and So-ciety of Thoracic Surgeons. J Am Coll Cardiol 2007; 50: e1-e157.
74. Christiansen JP, Edwards C, Sinclair T, et al. Detection of myocardial scar by contrast-Enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. Am J Cardiol 2006; 97: 768-71.
75. Aldous SJ. Cardiac biomarkers in acute myocardial in-farction. Int J Cardiol 2013; 164: 282-94.
76. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007; 28: 1242-9.
77. Majki-Singh N. What is a biomarker? From its discovery to clinical aplication. Journal of Medical Biochemistry 2011; 30: 186-92.
78. Bossuuyt MM P. Defining Biomarker performance and clinical validity. Journal of Medical Biochemistry 2011; 30: 193-200.
79. Sypniewska G, Bergmann K, Krintus M, Kozinski M, Kubica J. How do apolipoproteins ApoB and ApoA-I perform in patients with acute coronary syndromes. Journal of Medical Biochemistry 2011; 30: 237-243.
80. DeFilippi CR, Tocchi M, Parmar RJ, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 2000; 35: 1827-34.
81. Waxman DA, Hecht S, Schappert J, Husk G. A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol 2006; 48: 1755-62.
82. McFalls EO, Larsen G, Johnson GR, Apple FS, Goldman S, Arai A, et al. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med 2011; 124: 630-5.
83. Latini R, Masson S, Anand IS, et al. Val-HeFT Inves ti-gators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116: 1242-9.
84. Schreiber DH, Agbo C, Wu AH. Short-term (90 min) diagnostic performance for acute non-ST segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high sensitivity troponin I assay. Clin Biochem 2012; 45: 1295-301.
85. Buschmann IR, Bondke A, Elgeti T, Kühnle Y, Dietz R, Möckel M. Positive cardiac troponin I and T and chest pain in a patient with iatrogenic hypothyroidism and no coronary artery disease. Int J Cardiol 2007; 115: e83-5.